• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Soluble TNF receptors and kidney dysfunction in the elderly.可溶性肿瘤坏死因子受体与老年人的肾功能障碍。
J Am Soc Nephrol. 2014 Jun;25(6):1313-20. doi: 10.1681/ASN.2013080860. Epub 2014 Feb 7.
2
Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.2型糖尿病中可溶性肿瘤坏死因子受体1和2与肾病、心血管事件及全因死亡率的关联
Cardiovasc Diabetol. 2016 Feb 29;15:40. doi: 10.1186/s12933-016-0359-8.
3
Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.可溶性肿瘤坏死因子受体1与哥伦比亚2型糖尿病患者的估计肾小球滤过率降低有关。
J Diabetes Complications. 2016 Jul;30(5):852-7. doi: 10.1016/j.jdiacomp.2016.03.015. Epub 2016 Mar 17.
4
Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.可溶性肿瘤坏死因子受体与儿科慢性肾脏病肾功能障碍的严重程度相关。
Pediatr Nephrol. 2019 Feb;34(2):349-352. doi: 10.1007/s00467-018-4124-y. Epub 2018 Oct 29.
5
Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.循环组织蛋白酶-S 水平与小鼠和人类的 GFR 下降以及 sTNFR1 和 sTNFR2 水平相关。
Sci Rep. 2017 Feb 27;7:43538. doi: 10.1038/srep43538.
6
Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly.可溶性肿瘤坏死因子受体1(sTNFR1)与因癌症和心血管疾病导致的总死亡率增加相关——来自两个基于社区的老年队列研究的结果。
Atherosclerosis. 2014 Nov;237(1):236-42. doi: 10.1016/j.atherosclerosis.2014.09.005. Epub 2014 Sep 16.
7
Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study.老年男性的炎症、氧化应激、肾小球滤过率和蛋白尿:一项横断面研究。
BMC Res Notes. 2012 Sep 27;5:537. doi: 10.1186/1756-0500-5-537.
8
Potential Role of Soluble TNF-α Receptors in Diagnosis of Patients with Chronic Kidney Disease.可溶性肿瘤坏死因子-α受体在慢性肾脏病患者诊断中的潜在作用
Ann Clin Lab Sci. 2017 May;47(3):310-314.
9
Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.可溶性肿瘤坏死因子受体1与两个社区老年人群队列中的肾小球滤过率进展及慢性肾脏病发病率相关。
Cardiorenal Med. 2015 Oct;5(4):278-88. doi: 10.1159/000435863. Epub 2015 Jul 31.
10
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.1型糖尿病非蛋白尿患者中肿瘤坏死因子α和Fas介导途径标志物的血清浓度及肾功能
Clin J Am Soc Nephrol. 2009 Jan;4(1):62-70. doi: 10.2215/CJN.03010608. Epub 2008 Dec 10.

引用本文的文献

1
High level of soluble tumor necrosis factor receptors is associated with lower residual diuresis volume in patients on hemodialysis: An exploratory study.血液透析患者中高水平可溶性肿瘤坏死因子受体与较低残余尿量相关:一项探索性研究。
PLoS One. 2025 Apr 29;20(4):e0320019. doi: 10.1371/journal.pone.0320019. eCollection 2025.
2
The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease.慢性肾病患者中肿瘤坏死因子受体(TNFR1和TNFR2)与死亡率以及肾功能下降之间的关联。
Ups J Med Sci. 2024 Nov 25;129. doi: 10.48101/ujms.v129.10726. eCollection 2024.
3
Expression of TNFR1, VEGFA, CD147 and MCT1 as early biomarkers of diabetes complications and the impact of aging on this profile.TNFR1、VEGFA、CD147 和 MCT1 的表达作为糖尿病并发症的早期生物标志物,以及衰老对该特征的影响。
Sci Rep. 2023 Oct 20;13(1):17927. doi: 10.1038/s41598-023-41061-0.
4
Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis.游离DNA作为血液透析终末期肾病患者预后的标志物。
Clin Kidney J. 2020 Aug 24;14(5):1371-1378. doi: 10.1093/ckj/sfaa115. eCollection 2021 May.
5
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.12 种新型心血管生物标志物在稳定型冠状动脉疾病中的预后价值。哥本哈根 CLARICOR 试验安慰剂组的 10 年随访。
BMJ Open. 2020 Aug 20;10(8):e033720. doi: 10.1136/bmjopen-2019-033720.
6
Effects of Whole Plant Homogenate on Lipid Metabolism, Inflammatory Conditions and Liver Function of Dairy Cows during the Transition Period.全株匀浆对围产期奶牛脂质代谢、炎症状态及肝功能的影响
Animals (Basel). 2020 May 25;10(5):917. doi: 10.3390/ani10050917.
7
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial.稳定型缺血性心脏病主要心血管结局的预测因素(PREMAC):来自CLARICOR(克拉霉素用于稳定型冠心病患者)试验数据的统计分析计划
Diagn Progn Res. 2017 Mar 29;1:10. doi: 10.1186/s41512-017-0009-y. eCollection 2017.
8
Longitudinal effects of aging on plasma proteins levels in older adults - associations with kidney function and hemoglobin levels.老年人血浆蛋白水平随增龄的纵向变化及其与肾功能和血红蛋白水平的关系。
PLoS One. 2019 Feb 25;14(2):e0212060. doi: 10.1371/journal.pone.0212060. eCollection 2019.
9
The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease-results from the SUPRIM-trial.基于团体的认知行为疗法对冠心病患者炎症生物标志物的影响-来自 SUPRIM 试验的结果。
Ups J Med Sci. 2018 Sep;123(3):167-173. doi: 10.1080/03009734.2018.1490829. Epub 2018 Aug 8.
10
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.稳定型冠心病患者肿瘤坏死因子受体 1 和 2 与心血管事件的 10 年相关性:CLARICOR(克拉霉素对缺血性心脏病患者死亡率和发病率的影响)试验亚研究。
J Am Heart Assoc. 2018 Apr 23;7(9):e008299. doi: 10.1161/JAHA.117.008299.

本文引用的文献

1
Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.早期进行性肾脏功能衰退先于微量白蛋白尿的出现及其进展为大量白蛋白尿。
Diabetes Care. 2014;37(1):226-34. doi: 10.2337/dc13-0985. Epub 2013 Aug 12.
2
Inflammatory factors and exercise in chronic kidney disease.慢性肾脏病中的炎症因子与运动。
Int J Endocrinol. 2013;2013:569831. doi: 10.1155/2013/569831. Epub 2013 May 13.
3
Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.多种炎症生物标志物与社区人群中心血管事件及死亡的关系。
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1728-33. doi: 10.1161/ATVBAHA.112.301174. Epub 2013 May 2.
4
Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects.炎症的基线标志物与 1 型糖尿病患者向大量白蛋白尿进展有关。
Diabetes Care. 2013 Aug;36(8):2317-23. doi: 10.2337/dc12-2521. Epub 2013 Mar 20.
5
Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?现有的已批准用于其他适应证的药物能否延缓 1 型糖尿病肾病患者的肾功能下降?
Semin Nephrol. 2012 Sep;32(5):437-44. doi: 10.1016/j.semnephrol.2012.07.006.
6
Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases.肿瘤坏死因子受体:在肾脏疾病中的生物学和治疗潜力。
Am J Nephrol. 2012;36(3):261-70. doi: 10.1159/000342333. Epub 2012 Sep 5.
7
Signal transduction by tumor necrosis factor receptors.肿瘤坏死因子受体的信号转导。
Cell Signal. 2012 Jun;24(6):1297-305. doi: 10.1016/j.cellsig.2012.02.006. Epub 2012 Feb 20.
8
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.循环 TNF 受体 1 和 2 可预测 1 型糖尿病的 3 期 CKD。
J Am Soc Nephrol. 2012 Mar;23(3):516-24. doi: 10.1681/ASN.2011060628. Epub 2012 Jan 19.
9
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.循环 TNF 受体 1 和 2 可预测 2 型糖尿病的终末期肾病。
J Am Soc Nephrol. 2012 Mar;23(3):507-15. doi: 10.1681/ASN.2011060627. Epub 2012 Jan 19.
10
Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria.血清可溶性 TNFα 受体与无蛋白尿 2 型糖尿病患者肾功能障碍的关系。
Diabetes Res Clin Pract. 2011 May;92(2):174-80. doi: 10.1016/j.diabres.2011.01.008. Epub 2011 Feb 1.

可溶性肿瘤坏死因子受体与老年人的肾功能障碍。

Soluble TNF receptors and kidney dysfunction in the elderly.

机构信息

Centre for Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden;

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden;

出版信息

J Am Soc Nephrol. 2014 Jun;25(6):1313-20. doi: 10.1681/ASN.2013080860. Epub 2014 Feb 7.

DOI:10.1681/ASN.2013080860
PMID:24511129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4033380/
Abstract

The importance of TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in the development of kidney disease is being unraveled. Yet, community-based data regarding the role of sTNFRs are lacking. We assessed serum sTNFRs and aspects of kidney damage cross-sectionally in two independent community-based cohorts of elderly participants: Prospective Investigation of the Vasculature in Uppsala Seniors (n=815; mean age, 75 years; 51% women) and Uppsala Longitudinal Study of Adult Men (n=778; mean age, 78 years). Serum sTNFR1 correlated substantially with different aspects of kidney pathology in the Uppsala Longitudinal Study of Adult Men cohort (R=-0.52 for estimated GFR, R=0.22 for urinary albumin-to-creatinine ratio, and R=0.17 for urinary kidney injury molecule-1; P<0.001 for all), with similar correlations in the Prospective Investigation of the Vasculature in Uppsala Seniors cohort. These associations remained significant after adjustment for age, sex, inflammatory markers, and cardiovascular risk factors and were also evident in participants without diabetes. Serum sTNFR2 was associated with all three markers in the Prospective Investigation of the Vasculature in Uppsala Seniors cohort (P<0.001 for all). Our findings from two independent community-based cohorts confirm and extend results of previous studies supporting circulating sTNFRs as relevant biomarkers for kidney damage and dysfunction in elderly individuals, even in the absence of diabetes.

摘要

TNF-α 及其可溶性受体(sTNFR1 和 sTNFR2)在肾脏疾病发展中的重要性正在被揭示。然而,关于 sTNFR 在社区中的作用的数据还很缺乏。我们在两个独立的老年人社区队列中对血清 sTNFRs 和肾脏损伤的各个方面进行了横断面评估:乌普萨拉老年人血管前瞻性研究(n=815;平均年龄 75 岁;51%为女性)和乌普萨拉成年男性纵向研究(n=778;平均年龄 78 岁)。血清 sTNFR1 与乌普萨拉成年男性纵向研究队列中肾脏病理的不同方面密切相关(估计肾小球滤过率为 R=-0.52,尿白蛋白/肌酐比值为 R=0.22,尿肾损伤分子-1 为 R=0.17;所有 P<0.001),在血管前瞻性研究中的老年人群中也存在类似的相关性。在调整年龄、性别、炎症标志物和心血管危险因素后,这些相关性仍然显著,在没有糖尿病的参与者中也存在这些相关性。血清 sTNFR2 与血管前瞻性研究中的所有三个标志物相关(所有 P<0.001)。我们从两个独立的社区队列中得到的发现证实并扩展了之前的研究结果,表明循环 sTNFRs 是老年人群中肾脏损伤和功能障碍的相关生物标志物,即使在没有糖尿病的情况下也是如此。